Jacqueline P. Honerlaw

Apr 13, 2023 | nature.com | Harrison Zhang |Jacqueline P. Honerlaw |Sehi L’Yi |Yuk-Lam Ho |Vidul Ayakulangara Panickan |Katherine P Liao | +4 more

The value of large-scale, real-world data — from electronic health records (EHRs), for example — has been used to establish vaccine efficacy, to elucidate the genetic etiologies of diseases, and to advance epidemiological research1,2,3. Real-world data also have the potential to capture the wide spectrum of clinical features attributed to post-acute sequalae of SARS-CoV-2, also called long COVID, in diverse patient populations4.